These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4204181)

  • 1. Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma.
    Elias EG; Holyoke ED; Chu TM
    Dis Colon Rectum; 1974; 17(1):38-41. PubMed ID: 4204181
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoreactive carcinoembryonic antigen [CEA] levels in feces from colorectal cancer patients.
    Kitsukawa Y
    Jpn J Surg; 1979 Jun; 9(2):102-9. PubMed ID: 449127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of carcinoembryonic antigen measurement in feces of patients with colorectal cancer.
    Shimano T; Okuda H; Monden T; Inaji H; Mori T
    Dis Colon Rectum; 1987 Aug; 30(8):607-10. PubMed ID: 3622164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of carcinoembryonic antigen and gamma glutamyl transpeptidase in the study of the evolution of colorectal cancer.
    Steele L; Cooper EH; Mackay AM; Losowsky MS; Goligher JC
    Br J Cancer; 1974 Oct; 30(4):319-24. PubMed ID: 4155643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison between stool CEA and serum CEA in colorectal cancer measured by monoclonal anti-CEA antibody].
    Ishii K; Takemura K; Endo M
    Nihon Geka Gakkai Zasshi; 1985 Aug; 86(8):972. PubMed ID: 3903470
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinoembryonic antigen (CEA). Use and limitations of the CEA radioimmunoassay in the diagnosis and follow-up of colo-rectal carcinoma.
    Mach JP; Pusztaszeri G; MacDonald D; Bertholet MM
    Johns Hopkins Med J Suppl; 1974; 3():369-79. PubMed ID: 4421371
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors which influence the radioimmunoassay of carcinoembryonic antigen (CEA).
    Hughes NR
    Mol Immunol; 1980 May; 17(5):665-73. PubMed ID: 6783829
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma melatonin levels in patients suffering from colorectal carcinoma.
    Khoory R; Stemme D
    J Pineal Res; 1988; 5(3):251-8. PubMed ID: 3404397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma.
    Boey J; Cheung HC; Lai CK; Wong J
    World J Surg; 1984 Jun; 8(3):279-86. PubMed ID: 6464483
    [No Abstract]   [Full Text] [Related]  

  • 10. [The CEA-concentration in plasma of patients with colorectal carcinoma and polyps has been determined by radioimmunoassay (RIA, Z-gel-method)].
    Ziegenbein R; Jacobasch KH; Pilgrim G; Seifart W
    Arch Geschwulstforsch; 1980; 50(2):165-8. PubMed ID: 7436700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
    Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of carcinoembryonic antigen in feces for the diagnosis of colonic rectal cancers.
    Hara M; Watanabe S; Kitagawa M; Yasutomi M
    Am J Proctol; 1974 Apr; 25(2):67-76. PubMed ID: 4816805
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical application of carcinoembryonic antigen in patients with colorectal carcinoma.
    Savrin RA; Cooperman M; Martin EW
    Dis Colon Rectum; 1979; 22(4):211-5. PubMed ID: 467173
    [No Abstract]   [Full Text] [Related]  

  • 14. (Washington University Case Conference). Colorectal carcinoma and carcinoembryonic antigen (CEA).
    Ladenson JH; McDonald JM; Landt M; Schwartz MK
    Clin Chem; 1980 Jul; 26(8):1213-20. PubMed ID: 7389095
    [No Abstract]   [Full Text] [Related]  

  • 15. Faecal carcinoembryonic antigen in colorectal cancer patients.
    Stubbs RS; Nadkarni DM; Monsey HA
    Gut; 1986 Aug; 27(8):901-5. PubMed ID: 3732896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interest and limits of estimation of the carcinoembryonic antigen in colonic and rectal (author's transl)].
    Arnaud JP; Simon P; Ollier JC; Koehl C; Adloff M
    J Chir (Paris); 1979 Nov; 116(11):633-6. PubMed ID: 555768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of plasma CEA in patients with colorectal carcinoma.
    Koch M; McPherson TA
    J Surg Oncol; 1979 Dec; 12(4):319-25. PubMed ID: 522488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further investigations of immunoreactive carcinoembryonic antigen (CEA) in colorectal cancer patients--with particular emphasis on the correlation between immunoreactive CEA levels in tissue, feces and blood.
    Fujimoto S; Kitsukawa Y
    Jpn J Surg; 1981 Jan; 11(1):27-32. PubMed ID: 7311185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of CEA radioimmunoassay for the detection of recurrence of carcinoma of the large bowel (author's transl)].
    Jaquet H; Mach JP; Pettavel J
    Langenbecks Arch Chir; 1976 Nov; 342():243-9. PubMed ID: 994637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of colorectal carcinoma patients by repeated CEA radioimmunoassay.
    Mach JP; Vienny H; Jaeger P; Haldemann B; Egely R; Pettavel J
    Cancer; 1978 Sep; 42(3 Suppl):1439-47. PubMed ID: 709514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.